Immunocore Holdings plc - American Depositary Shares —— 现金流量表 (NASDAQ:IMCR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 ———2.94 M26.06 M-10.71 M -10.71 M 投资活动产生的现金 ———-5.42 M-355.13 M-16.34 M -16.34 M 融资活动产生的现金 ———34.35 M343.88 M12.37 M 12.37 M 自由现金流 ———-2.48 M20.89 M-15.05 M -15.05 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

新闻

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies因营收担忧下调Immunocore股票评级

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore在Leerink会议上展示战略增长与创新

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

Immunocore HoldingsQ4每股收益及营收逊于预期

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y